Here's What Key Metrics Tell Us About Biogen Inc. (BIIB) Q4 Earnings

Biogen Inc. (BIIB) reported $2.39 billion in revenue for the quarter ended December 2023, representing a year-over-year decline of 6.2%. EPS of $2.95 for the same period compares to $4.05 a year ago.The reported revenue represents a surprise of -2.88% over the Zacks Consensus Estimate of $2.46 billion. With the consensus EPS estimate being $3.16, the EPS surprise was -6.65%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...